Catalyst Wire Dossier Catalyst Wire Dossier

Bemdaneprocel

Bemdaneprocel · BlueRock Therapeutics
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Bemdaneprocel, covering 2026-04-01 to 2026-04-01. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Investigate the Efficacy and Safety of Bemdaneprocel in Adults Who Have Parkinson's Disease [Phase 3]

See pricing